Demonstrated recognition of 15 out of 20 amino acids, representing a path to more than 70% coverage of the human proteome.

Released an application note demonstrating the use of Quantum-Si’s PlatinumTM sequencing instrument to directly sequence arginine post-translational modifications.

Executing well on supply chain initiatives, including the build-up of PlatinumTM instrument inventory and scale-up of semiconductor chip and reagent kit production.

Increased efforts to manage costs and improve efficiencies, expecting operating expenses to grow 40-50% year-over-year in 2022, down from a prior expectation of 70-80%.